Thibault D. L. M. R.
- Country
- France
- Department
- Service d'Oncologie Médicale
Research Overview
- Evaluation of MAQ-001 Monotherapy and Combination Therapy in Advanced Cancers with Approved Immune Checkpoint Blockade Options
- Phase 1 Open-Label Study of CTPS1 Inhibitor STP938 in Advanced Solid Tumors and CTPS2 Null Ovarian Cancer
- Phase I Evaluation of NI-1801 Monotherapy and Combination with Anti-PD-1 or Paclitaxel in Advanced Mesothelin-Expressing Solid Tumors
Data & Insights
Has run more than one trial at 248 of 504 partner sites.
Specializations
Gynecologic Oncology
Specialized in treating advanced ovarian cancer, cervical cancer, and endometrial carcinoma through innovative therapeutic approaches.
- Platinum-resistant ovarian cancer treatment
- Locally advanced cervical cancer therapies
- Maintenance treatment strategies
Focuses on integrating targeted therapies with immunotherapy approaches for gynecologic malignancies.
Breast Cancer Research
Expertise in treating various subtypes of breast cancer, with particular focus on HER2-positive breast cancer and triple-negative breast cancer.
- Early detection strategies
- Metastatic disease management
- Novel therapeutic combinations
Specializes in biomarker-driven treatment approaches and targeted therapies.
Advanced Solid Tumors
Conducts research on novel therapeutic agents for various solid malignancies, including lung cancer and rare tumor types.
- Immunotherapy combinations
- Targeted molecular therapies
- Biomarker-driven treatments
Implements innovative treatment strategies for patients with advanced or metastatic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.